Crossmark

Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase III

Crossref DOI link: https://doi.org/10.1007/s00277-019-03681-3

Published Online: 2019-05-21

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niedeggen, Cathrin

Singer, Susanne

Groth, Martha

Petermann-Meyer, Andrea

Röth, Alexander

Schrezenmeier, Hubert

Höchsmann, Britta

Brümmendorf, Tim H.

Panse, Jens https://orcid.org/0000-0001-6316-3112
License Information

Text and Data Mining valid from 2019-05-21

Version of Record valid from 2019-05-21
More Information

Article History

Received: 23 May 2018

Accepted: 28 March 2019

First Online: 21 May 2019

Compliance with ethical standards

: The data protection official of the University Hospital RWTH Aachen and the Institutional Review Board of the Medical Faculty RWTH Aachen University approved the study protocol.

: The authors declare that they have no conflict of interest.

: This article does not contain any studies with human participants performed by any of the authors.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below